Vitamin d 25 hydroxy
Pro Research Analysisby 
Searched over 200M research papers
The Role of Vitamin D 25-Hydroxy in Health: Insights from Recent Research
Vitamin D 25-Hydroxy and Cardiovascular Disease Risk
Cardiovascular Disease (CVD) Incidence and Mortality
Research has consistently shown a significant association between low levels of 25-hydroxy-vitamin D (25[OH]D) and an increased risk of cardiovascular disease (CVD). A meta-analysis of 24 prospective studies involving 65,994 participants found that individuals with the lowest levels of 25(OH)D had a 52% higher risk of total CVD compared to those with the highest levels. This association was also observed for CVD mortality, coronary heart disease, and stroke 1. Another systematic review and meta-analysis of 79 studies confirmed that lower 25(OH)D levels were linked to a higher risk of both CVD incidence and recurrent CVD events 4. These findings suggest a generally linear, inverse relationship between 25(OH)D levels and CVD risk, particularly below 60 nmol/L 14.
Dose-Response Relationship
Further analysis has demonstrated a dose-response relationship between 25(OH)D levels and CVD risk. For every 10 ng/mL increase in 25(OH)D, there was a 10% reduction in the risk of total CVD events and a 12% reduction in CVD mortality 10. This inverse association highlights the potential cardiovascular benefits of maintaining adequate 25(OH)D levels.
Vitamin D 25-Hydroxy and Mortality
All-Cause Mortality
Low levels of 25(OH)D have also been associated with increased all-cause mortality. A meta-analysis of 26,916 individuals from a European consortium found that participants with 25(OH)D levels below 30 nmol/L had a 67% higher risk of mortality compared to those with levels between 75 and 99.99 nmol/L 3. This study underscores the importance of maintaining sufficient 25(OH)D levels to potentially reduce the risk of premature death.
Cancer Mortality
Interestingly, while low 25(OH)D levels were linked to higher cardiovascular mortality, no significant linear association was found between 25(OH)D levels and cancer mortality 3. This suggests that the protective effects of 25(OH)D may be more pronounced for cardiovascular health than for cancer outcomes.
Vitamin D 25-Hydroxy and Type 2 Diabetes
Diabetes Risk Reduction
Higher levels of 25(OH)D have been associated with a lower risk of developing type 2 diabetes. A meta-analysis of 21 prospective studies involving 76,220 participants found that individuals with the highest 25(OH)D levels had a 38% lower risk of type 2 diabetes compared to those with the lowest levels 8. Each 10 nmol/L increase in 25(OH)D was associated with a 4% reduction in diabetes risk, indicating a clear inverse relationship between 25(OH)D levels and the incidence of type 2 diabetes 8.
Vitamin D Supplementation and 25-Hydroxy Vitamin D Levels
Efficacy of Supplementation
Vitamin D supplementation has been shown to effectively increase 25(OH)D levels, particularly in individuals with initially low levels. A study on elderly patients found that a daily dose of 500 IU of vitamin D significantly increased 25(OH)D levels within two months, with diminishing returns at higher initial levels 5. Another study determined that an optimal daily dose of 95-125 micrograms (3800-5000 IU) of vitamin D3 was necessary to achieve serum 25(OH)D concentrations above 75 nmol/L in most individuals 6.
Genetic Factors
Genetic variations can influence the efficacy of vitamin D supplementation. Specific single nucleotide polymorphisms (SNPs) in genes related to vitamin D metabolism, such as CYP2R1, CYP24A1, and VDR, have been found to modify the increase in 25(OH)D levels following vitamin D3 supplementation 7. This suggests that personalized approaches to vitamin D supplementation may be necessary to achieve optimal 25(OH)D levels in different individuals.
Conclusion
Maintaining adequate levels of 25-hydroxy-vitamin D is crucial for reducing the risk of cardiovascular disease, all-cause mortality, and type 2 diabetes. Vitamin D supplementation is an effective strategy to increase 25(OH)D levels, particularly in individuals with low baseline levels. However, genetic factors may influence the response to supplementation, highlighting the need for personalized approaches. Further research is needed to fully understand the optimal 25(OH)D levels for various health outcomes and to develop tailored supplementation strategies.
Sources and full results
Most relevant research papers on this topic
Circulating 25-Hydroxy-Vitamin D and Risk of Cardiovascular Disease: A Meta-Analysis of Prospective Studies
Higher circulating 25(OH)-vitamin D levels are associated with a reduced risk of cardiovascular disease, with a linear inverse association between 20 and 60 nmol/L.
Meta-Analysis
Highly CitedAre clinical laboratories prepared for accurate testing of 25-hydroxy vitamin D?
Clinical laboratories need standardized methods for accurate 25-hydroxy vitamin D testing, as the volume of tests performed is expected to increase by 80% to 90% per year in the US.
Systematic ReviewHighly CitedVitamin D and mortality: Individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium
Low vitamin D levels are associated with an increased risk of all-cause mortality, suggesting that treatment of vitamin D deficiency may prevent premature deaths.
Meta-Analysis
Rigorous JournalHighly CitedCirculating 25-hydroxy-vitamin D and the risk of cardiovascular diseases. Systematic review and meta-analysis of prospective cohort studies.
The lowest category of circulating 25(OH)D is associated with a higher risk of cardiovascular disease incidence events and recurrent events.
Meta-AnalysisVitamin D supplements and 25-hydroxy vitamin D concentrations in the elderly.
A daily dose of 500 IU vitamin D significantly increases 25-hydroxy vitamin D levels in elderly patients, potentially preventing osteomalacia and promoting bone health.
RCTVitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration.
Optimal daily vitamin D intake is 115 micrograms per day (4600 IU) to achieve serum 25-hydroxyvitamin D concentrations >75 nmol/L, considering variability in dose-response curves and basal levels.
RCT
Very Rigorous JournalHighly CitedGenetic variants in CYP2R1, CYP24A1, and VDR modify the efficacy of vitamin D3 supplementation for increasing serum 25-hydroxyvitamin D levels in a randomized controlled trial.
Vitamin D3 supplementation's effectiveness in increasing serum 25-hydroxyvitamin D levels may vary based on common genetic differences in vitamin D 25-hydroxylase, 24-hydroxylase, and vitamin D receptor genes.
RCT
Large Human TrialRigorous JournalHighly CitedBlood 25-Hydroxy Vitamin D Levels and Incident Type 2 Diabetes
Higher blood 25-hydroxy vitamin D levels are associated with a lower risk of type 2 diabetes across diverse populations.
Meta-AnalysisVery Rigorous JournalHighly CitedA pilot-randomized, double-blind crossover trial to evaluate the pharmacokinetics of orally administered 25-hydroxyvitamin D3 and vitamin D3 in healthy adults with differing BMI and in adults with intestinal malabsorption.
Oral 25(OH)D3 may be a better choice for managing vitamin D deficiency in malabsorption and obesity due to its more hydrophilic nature.
RCTVery Rigorous JournalSerum 25-hydroxyvitamin D and the risk of cardiovascular disease: dose-response meta-analysis of prospective studies.
Higher serum 25(OH)D levels are associated with a reduced risk of total cardiovascular disease events and mortality.
Meta-AnalysisVery Rigorous JournalHighly Cited